companydata.dkcompanydata.dk

Incyte Biosciences Denmark ApS: Financial statements 2024

CVR: 35818790

Source: annual report 2024, Danish Business Authority

01/01/2024 – 31/12/2024

Incyte Biosciences Denmark ApS (CVR 35818790) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 7,046,348 and a net result of DKK 368,873 compared with DKK 374,584 the year before. That is an increase of 12.1% compared with the year before. Equity in the 2024 report amounted to DKK 1,967,345. The solvency ratio was 52.6%. The company had 4 employees in the financial year.

Gross Profit
DKK 7,046,348
Profit/Loss
DKK 368,873
Equity
DKK 1,967,345
Total Assets
DKK 3,739,819
Employees
4

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-7M369K2M4
2023-6.3M375K1.6M4
2022-5.6M278K1.2M4
2021-5.3M269K946K4
2020-5.4M150K677K3

Official annual report

View the official annual report directly on the page with a Pro subscription.

Screen every Danish company

Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.

Try company screening

Events in 2024

Lee Jason Heeson joins the board of Incyte Biosciences Denmark ApSOct 1, 2024

As of October 1, 2024, Lee Jason Heeson has joined the board of directors of Incyte Biosciences Denmark ApS.

Jonathan Elliot Dickinson leaves the board of Incyte Biosciences Denmark ApSSep 30, 2024

As of September 30, 2024, Jonathan Elliot Dickinson has left the board of directors of Incyte Biosciences Denmark ApS.

Incyte Biosciences Denmark ApS: The 2023 annual report is outMay 28, 2024

Incyte Biosciences Denmark ApS has published its annual report for 2023. Gross profit came to DKK 6,283,403, and the net result was DKK 374,584.

Incyte Biosciences Denmark ApS appoints new auditorApr 12, 2024

As of April 12, 2024, Grant Thornton, Godkendt Revisionspartnerselskab has been appointed auditor of Incyte Biosciences Denmark ApS.

About Incyte Biosciences Denmark ApS

Incyte Biosciences Denmark ApS is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 2014. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named ARIAD PHARMACEUTICALS (DENMARK) ApS. The management consists of Ebba Cecilia Bröms. The board consists of Lee Jason Heeson (chair) and Ebba Cecilia Bröms. The company is owned by Incyte Biosciences International Sàrl. The company has 4 employees (2026). In 2025, the company reported a gross profit of DKK 6,696,586 and a net result of DKK 361,151 compared with DKK 368,873 the year before. Equity in the 2025 report amounted to DKK 2,328,496.

Source: annual report 2025, Danish Business Authority